University of Florida

Almut Winterstein, Ph.D.
Assistant Professor

Education

B.S. Pharmacy, Friedrich Wilhelm University, Bonn

Ph.D. Pharmacoepidemiology and Social Pharmacy, Humboldt University, Berlin

Research interest

Pharmacoepidemiology and Drug Safety

Patient Safety and Quality of Care

Almut Winterstein is presently an Assistant Professor at the College of Pharmacy and Affiliate Assistant Professor at the College of Public Health and Health Professions at the University of Florida.  Her research interests focus on drug safety and effectiveness post-marketing, and the evaluation and prevention of inappropriate drug use.  Her pharmacoepidemiologic work is conducted in conjunction with the Perry A Foote Laboratory for Outcomes Research and Pharmacoeconomics, and concentrates on various clinical specialties, including diabetes mellitus, cardiological disorders, nephrotoxicity, and vulnerable population such as geriatrics and pediatrics.  Quality improvement activities are centered around her appointment as epidemiologist at the Clinical Practice Committee and the Medication Safety Committee at UF&Shands hospital and consultant activities for the Florida Department of Rural Health.  Research projects deriving from these and others include the development and evaluation of medication safety programs and clinical decision support systems and quality metrics.

Almut has experience with various large databases, including Medicaid claims data, hospital administrative and clinical databases, various pharmacy medication record systems, and national databases maintained by NCHS and AHQR.  Special methodological interests include observational studies, methods to adjust for bias, and meta-analysis.

Almut teaches Evidence-based Pharmacy in the College of Pharmacy professional PharmD program and Pharmacoepidemiology in the department’s PhD program. She is a chair of the Research Advisory Board of the American Society of Health Systems Pharmacist Research and Education Foundation, member of the scientific committee of the Pharmaceutical Care Foundation Germany, and special advisor to the Governor’s Advisory Board for the Implementation of Health Information technology in Florida.

References:

Publications

Hartzema AG, Winterstein AG, Johns T, De Leon J, Baily W, McDonald K, Pannell R.  Planning for Pharmacy Health Informaton technology (pHIT) in Critical Access Hospitals.  America Journal of Health System Pharmacy (in print)

Shuster J, Winterstein AG. Interrupted time series was accurate in showing improvement in medication errors. J Clin Epidem 2006 (in print)

Beaver TM, Winterstein AG, Shuster JJ, Gerhard T, Martin T, Alexander JA, Johnson RJ, Ejaz A, Hartzema AG. Effectiveness of nesiritide on dialysis or all-cause mortality in patients undergoing cardiothoracic surgery. Clin Cardiol 2006;29:18-24

Winterstein AG , Hartzema AG, Johns JE, DeLeon JM, McDonald K, Henshaw Z, Pannell R. Medication Safety Infrastructure in critical access hospitals in Florida. American Journal of Health Systems Pharmacy 2006; 63(5):442-450

Pasanen AL, Edwards E, Annis LG, Guyer LK, Winterstein AG. The Influence of Age on Knowledge and Medication Usage by Persons Attending Rural North Florida Clinics. Florida Public Health Review (in print)

Gerhard T, Zineh I, Winterstein AG, Hartzema AG. Pharmacoeconomic modeling of nesiritide versus dobutamine for decompensated heart failure. Pharmacother 2006;26(1):34–43

Winterstein AG , Hartzema AG. Pharmacy-specific quality indicators for asthma therapy. Research in Social and Administrative Pharmacy. 2005;1:430-445

Smith WD, Winterstein AG, Johns TE, Rosenberg EI, Sauer BC. Causes of Hyper- and Hypoglycemia in adult medical and surgical patients. Am J Health Syst Pharm 2005;62 714-719

Winterstein AG , Johns TE, Rosenberg EI, Hatton RC, Gonzalez-Rothi R. Nature and causes of clinically significant medication errors in hospitals: Results of a unique multidisciplinary prospective data collection method. Am J Health Syst Pharm. 2004 Sep 15;61(18):1908-16

Kanjanarat P, Winterstein AG, Johns TE, Gonzalez-Rothi R, Hatton RC, Segal R, The nature of preventable adverse drug events in hospitals: a literature review. American Journal of Health-System Pharmacists 2003;60:1750-9

Winterstein AG , Hatton RC, Gonzalez-Rothi R, Johns TE, Segal R. High-priority preventable adverse drug events identified from a hospital ADR report database. Am J Health-Syst Pharm 2002;59:1742-9

Brushwood DB, Winterstein AG. Manufacturer Warnings of System-Related Medication Errors. American Journal of Health-Systems Pharmacy 2002;59:1110-1112

Winterstein AG , Sauer BC, Hepler CD, Poole C. Preventable drug-related hospital admissions. Annals of Pharmacotherapy 2002;36:1238-1248

Bernsten C, Bjorkman I, Caramona M, Crealey G, Frokjar B, Grundberger E, Gustafsson T, Henman M, Herborg H, Hughes C, McElnay J, Magner M, van Mil F, Schaefer M, Silva S, Sondergaard B, Sturgess I, Tromp D, Vivero L, Winterstein A, on behalf of the Pharmaceutical Care of the Elderly in Europe Research (PEER) Group. Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care – a multi-center study in seven European countries. Drugs & Aging 2001;18(1):63-77

Winterstein AG , Jopp R, Schaefer M. Aeltere multimorbide Patienten werden in Apotheken gut betreut – Ergebnisse der OMA Studie Teil 1. [Pharmaceutical Care for elderly multimorbide patients – results of the OMA study, part 1] Pharm Ztg 2001;146(11): 833 - 841

Winterstein AG , Jopp R, Schaefer M. Gesundheitsbezogene Lebensqualität als wichtiges Zielkriterium [Health-related quality of life as important health outcome] Pharm Ztg. 2001;146 (12):936 - 942

Winterstein AG , Jopp R, Schaefer M. Patienten profitieren von der Pharmazeutischen Betreuung [Patient benefit from pharmaceutical care] Pharm Ztg. 2001;146 (13):1024-1033

Schaefer M., Bergmann KC., Schulz M., Mühlbauer K., Müller-Jaeger A., Kahmen U.: Pharmazeutische Betreuung – Arzt und Apotheker auf dem Weg in die Zukunft. [Pharmaceutical Care – physician and pharmacist on their way to future], Münch Med Wschr. 1998; 140(23): 343-345.

Müller-Jaeger A. , Pharmaceutical care – nutzbringende Innovation für die Gesundheitsversorgung, [Pharmaceutical Care: beneficial innovation in health care] Apothekenpraxis (1998)

Belgardt C., Krishnan HS., Müller-Jaeger A., Räuscher E.:, Qualität der Pharmakotherapie sichern. [Assure quality of pharmacotherapy] Pharm Ztg. 1997; 142(3): 152- 154

Belgardt C, Krishnan HS, Müller-Jaeger A, Räuscher E. Social pharmacy goes west. Pharm Ztg. 1997; 142 (1/2): 38-40

Müller-Jaeger A ., Erkennen wie uns andere sehen. [Recognize how others see us.] Pharm Ztg. 1997; 142(7): 527-531

Van Mil JWF., Müller-Jaeger A., Schaefer M., Tromp Th.: Pharmazeutische Betreuung: Fortschritte und Erfahrungen in den Niederlanden. [Pharmaceutical Care: progress and experiences in the Netherlands] Pharm Ztg. (1997) 142(25): 2543-49

Müller-Jaeger A. , Schaefer M., Pharmaceutical Care in der Praxis: Startschuss für Pilotprojekt in Berlin. [Pharmaceutical Care in practice: go-ahead for a pilot project in Berlin] Pharm Ztg. 1996; 141(30): 2739-2748

Schaefer M., Müller-Jaeger A., Belgardt C.: Berlin startet bundesweit erste Studie. [Pharmaceutical Care- Berlin starts first national study] Pharm Ztg. 1996; 33(141): 44-45

(Almut Winterstein, formerly Almut Müller-Jaeger)

Book Chapters

Winterstein AG , Pharmakooekonomie [Pharmaco-economics] (chapter 7), in Weinzierl S (ed.) Praxis der Arzneimittelinformation [Practice of Drug Information], Govi Verlag, Eschborn, 2002

 

© University of Florida
Contact Webmaster for questions about this website
Last modified March 23, 2006